-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
July 01, 2011 - Layout 1
Backgrounda
Obstructive sleep apnea (OSA) is a
relatively common disorder in the United
States … Ongoing
debate surrounds what type and level of
respiratory abnormality should be used to
define the disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
February 22, 2012 - Prevalence of otologic complaints in patients with
temporomandibular disorder. … Tinnitus, dizziness, and nonotologic otalgia improvement
through temporomandibular disorder therapy
-
effectivehealthcare.ahrq.gov/products/psychiatric-readmissions/research-protocol
September 04, 2014 - rates
Secondary outcomes
Treatment adherence
Housing stability
Social support
Remission of disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psychiatric-readmissions_research-protocol.pdf
December 31, 2014 - Secondary outcomes
§ Treatment adherence
§ Housing stability
§ Social support
§ Remission of disorder
-
effectivehealthcare.ahrq.gov/products/trauma-child-interventions/research
February 11, 2013 - Current Page Topic Timeline Oct. 28, 2010 Topic Suggestion Mar. 26, 2012 Research Protocol Feb. 11, 2013 Systematic Review Jun. 28, 2013 Disposition of Comments Report Child and Adolescent Exposure to Trauma: Comparative Effectiveness of Interventions Addressing Trauma Other Than Maltreatment or Family Violence
Sys…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/healthcare-system-appendixes-draft-technical-brief.pdf
February 01, 2023 - disease* or chronic obstructive pulmonary
disease or COPD or diabetes or HIV or hypertension or mental disorder … chronic N3 (condition* OR
disease* OR illness*)) or (TI ("long term conditions") OR (TI (mental N3 (disorder … chronic N3 (condition* OR disease* OR illness*)) or (AB ("long term
conditions") OR (AB (mental N3 (disorder … ) OR
A-4
TITLE-ABS ( "HIV" ) OR TITLE-ABS ( hypertension ) OR TITLE-ABS ( mental W/5
disorder … United States Preventative Services Task Force; ED = emergency department; PTSD = post-traumatic
stress disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-noninvasive-nonpharma.pdf
August 01, 2022 - nonopioid pharmacologic therapy or
nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … treatment, what is
the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder … Patients currently under treatment for opioid use disorder with opioid
agonist therapy or naltrexone … pharmacologic
therapy, nonpharmacologic therapy
KQ1 f: Reference standard for misuse, opioid use disorder … Misuse, opioid use disorder, overdose and other harms
KQ2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-noninvasive-nonpharma.pdf
August 01, 2022 - nonopioid pharmacologic therapy or
nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … treatment, what is
the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder … Patients currently under treatment for opioid use disorder with opioid
agonist therapy or naltrexone … pharmacologic
therapy, nonpharmacologic therapy
KQ1 f: Reference standard for misuse, opioid use disorder … Misuse, opioid use disorder, overdose and other harms
KQ2.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - nonopioid pharmacologic therapy or
nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … treatment, what is
the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder … Patients currently under treatment for opioid use disorder with opioid
agonist therapy or naltrexone … pharmacologic
therapy, nonpharmacologic therapy
KQ1 f: Reference standard for misuse, opioid use disorder … Misuse, opioid use disorder, overdose and other harms
KQ2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - nonopioid pharmacologic
therapy or nonpharmacologic therapy with respect to: (1) misuse, opioid
use disorder … treatment, what is the effectiveness of instruments for
predicting risk of opioid misuse, opioid use disorder … Patients currently under treatment for opioid use disorder with opioid
agonist therapy or naltrexone … pharmacologic
therapy, nonpharmacologic therapy
KQ1 f: Reference standard for misuse, opioid use disorder … Misuse, opioid use disorder, overdose and other harms
KQ2.
-
effectivehealthcare.ahrq.gov/products/transparency-tympanostomy/research-protocol
September 03, 2016 - Transparency of Reporting Requirements: Tympanostomy Tubes
Research Protocol September 3, 2016 Download Main Document PDF 295.4 KB
Background
Information biases, including publication bias, time-lag bias, selective outcome reporting bias, selective analysis bias, and fraud are major threats to the val…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
March 01, 2011 - Utilization of antidiabetic drugs among Medicare
beneficiaries with diabetes, 2006-2009
Diabetes Treatment Data Points #9
Biguanides (i.e., metformin)
were the most commonly used
antidiabetic drug class among
Medicare beneficiaries from 2006 to
2009, followed by sulfonylureas,
insulins, and thiazolidinediones…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research-protocol.pdf
September 02, 2016 - Transparency of Reporting Requirements: Tympanostomy Tubes
Source: www.effectivehealthcare.ahrq.gov
Published online: September 2, 2016
Evidence-based Practice Center Methodology Repor t Protocol
Project Title: Transparency of Repor ting Requirements
Repor t Topic: Tympanostomy Tubes
I. Background
Info…
-
effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
October 01, 2007 - Advisory
Panels addressed the safety of stimulant drugs prescribed for
attention deficit hyperactivity disorder … Stimulant medications and attention
deficit-hyperactivity disorder.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
September 01, 2011 - to autism spectrum disorder and determined
that this outcome was more appropriately
related to terbutaline … Previously, we reviewed the literature related
to autism spectrum disorder and determined
that this
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
September 18, 2012 - Ileal-lymphoid-nodular hyperplasia, non-
specific colitis, and pervasive developmental disorder in children … Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive
developmental disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
October 01, 2007 - 1.9% 2.7% 0.05
Cancer (excluding nonmelanoma skin
cancer)
5.3% 5.7% 0.47 5.2% 5.5% 0.60
Adjustment disorder
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
April 01, 2021 - efficacy of
home blood pressure monitoring during pregnancy, and included pregnancies with hypertensive
disorder
-
effectivehealthcare.ahrq.gov/products/dementia-agitation-aggression/research-protocol
November 13, 2014 - Current Page Topic Timeline Mar. 7, 2013 Topic Suggestion Nov. 13, 2014 Research Protocol Mar. 21, 2016 Systematic Review Non-pharmacologic Interventions for Agitation and Aggression in Dementia
Research Protocol Archived November 13, 2014 Download Main Document PDF 716.1 KB
Archived: This report is …
-
effectivehealthcare.ahrq.gov/products/weight-gain-prevention/research-protocol
October 25, 2011 - Current Page Topic Timeline Jun. 15, 2011 Topic Initiated Oct. 25, 2011 Research Protocol Mar. 25, 2013 Systematic Review Jul. 26, 2013 Disposition of Comments Report Comparative Effectiveness of Approaches to Weight Maintenance in Adults
Research Protocol Archived October 25, 2011 Download Main Document PDF 446.5…